HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inherited dup(17)(p11.2p11.2): expanding the phenotype of the Potocki-Lupski syndrome.

Abstract
Potocki-Lupski syndrome (PTLS, OMIM: 610883) is a microduplication syndrome characterized by infantile hypotonia, failure to thrive, cardiovascular malformations, developmental delay, intellectual disability, and behavior abnormalities, the latter of which can include autism spectrum disorder. The majority of individuals with PTLS harbor a de novo microduplication of chromosome 17p11.2 reciprocal to the common recurrent 3.6 Mb microdeletion in the Smith-Magenis syndrome critical region. Here, we report on the transmission of the PTLS duplication across two generations in two separate families. Individuals in these families presented initially with developmental delay, behavior problems, and intellectual disability. We provide a detailed review of the clinical and developmental phenotype of inherited PTLS in both families. This represents the second report (second and third families) of PTLS in a parent-child pair and exemplifies the under-diagnosis of this and likely other genetic conditions in adults with intellectual disability and/or psychiatric disorders.
AuthorsPilar L Magoulas, Pengfei Liu, Violet Gelowani, Claudia Soler-Alfonso, Emma C Kivuva, James R Lupski, Lorraine Potocki
JournalAmerican journal of medical genetics. Part A (Am J Med Genet A) Vol. 164A Issue 2 Pg. 500-4 (Feb 2014) ISSN: 1552-4833 [Electronic] United States
PMID24311450 (Publication Type: Case Reports, Journal Article, Review)
Copyright© 2013 Wiley Periodicals, Inc.
Topics
  • Abnormalities, Multiple
  • Adult
  • Child, Preschool
  • Chromosome Disorders
  • Chromosome Duplication
  • Chromosomes, Human, Pair 17
  • Comparative Genomic Hybridization
  • Facies
  • Female
  • Humans
  • Infant
  • Male
  • Pedigree
  • Phenotype
  • Smith-Magenis Syndrome (diagnosis, genetics)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: